Treatment(s) already received-Radiation Posts on Medivizor
Navigation Menu

Treatment(s) already received-Radiation Posts on Medivizor

Does remission status influence outcomes of SCT for patients with Hodgkin’s lymphoma?

Posted by on Sep 21, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the outcomes of allogeneic stem cell transplantation (SCT) in patients with classical Hodgkin’s lymphoma (CHL) that was refractory (resistant to treatment) or had relapsed. The study found that patients in complete remission (no signs of cancer) when they received the transplant had better outcomes. Some...

Read More

Evaluating the safety of re-treatment with radium-223

Posted by on Sep 16, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the safety and effectiveness of radium-223 (Xofigo, formerly known as Alpharadin) in patients with advanced prostate cancer that has spread to the bones and who have had this treatment previously. This study found that re-treatment with radium-223 was well tolerated and with good results. Some background...

Read More

Searching for patients to try a new therapy for advanced solid tumors.

Posted by on Jul 24, 2019 in Colorectal cancer | 0 comments

In a nutshell This study is searching for participants with advanced solid tumors to try a new treatment called repotrectinib (TPX-0005). The main outcomes that will be measured include side effects, the most effective dose and response. This trial is recruiting in the United States and Korea. The details Patients with different genetic mutations...

Read More

The risk of pelvic fracture in rectal cancer survivors who had radiotherapy

Posted by on Jun 14, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the risk of pelvic fracture (PF) in patients with rectal cancer who received radiation therapy. Researchers suggested that there is an increased risk of PF in these patients. Some background Rectal cancer rates have been increasing, especially in younger populations. Due to improvements in medical care, survival...

Read More

Searching for patients with non-small cell lung cancer to trial a new targeted therapy drug

Posted by on May 11, 2019 in Lung cancer | 0 comments

In a nutshell This phase 3 trial will investigate the safety and effectiveness of osimertinib (Tagrisso) after chemoradiation (CR) in non-small cell lung cancer (NSCLC). The main outcome will be progression-free survival (PFS; survival without cancer growing or spreading). The details Non-small cell lung cancer (NSCLC) is the most...

Read More

Searching for patients to try a new combination of treatments for relapsed or unresponsive Hodgkin lymphoma.

Posted by on Apr 22, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study will investigate the effects of pembrolizumab (Keytruda) and targeted radiation therapy for relapsed or unresponsive Hodgkin lymphoma (HL). This study will measure the rate of complete response (disappearance of all cancer). The details Many patients are cured with treatments for HL. Some patients lose response to...

Read More

How long should hormonal therapy continue in patients who have received postprostatectomy radiotherapy?

Posted by on Mar 26, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined how long hormonal therapy should continue in patients who have received radiotherapy after prostate removal surgery (prostatectomy). This study concluded that patients with a higher number of risk risk factors should receive HT for a longer period of time.  Some background Radical prostatectomy (RP) is...

Read More

Searching for patients to test a new treatment for unresponsive multiple myeloma.

Posted by on Feb 9, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial is comparing the effectiveness of a new therapy, bb2121, to commonly used combinations of drugs for relapsing/refractory (unresponsive) multiple myeloma (RRMM). The main outcome to be measured is the time from the start of treatment until cancer worsens. The details Many patients are cured with standard treatments, such as...

Read More

A review of adolescent Hodgkin lymphoma.

Posted by on Jan 24, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study reviewed how the research on pediatric and adult Hodgkin lymphoma (HL) could be applied to adolescent HL. The main finding was that treatments for pediatric and adult HL have similar effects in adolescent HL. Some background About 8500 people are diagnosed with HL in the US each year. There are 2 main types of HL:...

Read More